细胞癌中的NK细胞及其对CAR-NK治疗的影响
Xinwei Li1,2, Yuanpeng Zhang1,2, Yuzhong Ye1,2,3
1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in cell and developmental biology
|March 7, 2025
概括
化学抗原受体NK细胞 (CAR-NK) 疗法对晚期细胞癌 (RCC) 有前途. 本综述探讨NK细胞机制及其在RCC中的作用,强调了CAR-NK治疗针对癌细胞的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症治疗 癌症治疗
背景情况:
- 细胞癌 (RCC) 占成人癌症的3%,其中20-30%在转移阶段被诊断出来.
- 用全身疗法治疗转移性RCC的平均整体存活期为16-50个月.
- 免疫疗法为晚期RCC提供了潜在的治疗途径.
研究的目的:
- 审查自然杀手 (NK) 细胞的细胞毒性机制.
- 总结一下RCC和NK细胞之间的关系.
- 提供关于治疗细胞癌的CAR-NK疗法的见解.
主要方法:
- 关于NK细胞,RCC和CAR-NK疗法的现有研究的文献综述.
- 分析NK细胞细胞毒性机制及其与RCC相关性的分析.
- 在RCC中探索CAR-NK治疗的潜在分子标.
主要成果:
- NK细胞具有与癌症治疗相关的细胞毒性机制.
- 针对RCC的CAR-NK疗法的具体研究正在出现.
- 了解RCC中的NK细胞相互作用可以为治疗策略提供信息.
结论:
- CAR-NK疗法是治疗晚期细胞癌的一个有前途的方法.
- 进一步研究NK细胞介导的细胞毒性和RCC中的免疫逃逸是有必要的.
- 确定分子点对于推进RCCCAR-NK疗法至关重要.
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457


